Olwadamilola Fayanju, MD
Surgery · Philadelphia, PANPI 1790980613
Payments from drug & device makers
What this record shows
4 manufacturers reported payments, led by AstraZeneca at 55.5% of the total. That places this record below the midpoint for surgery clinicians in PA, where the typical reported total is $1,143.
Across 5 payments — averaging $193.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$537
- Stryker$200
- Elucent Medical$144
- Baxter Healthcare$86
Across 6 payments — averaging $111,111 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$667K
What the payments were for
- Consulting fees$53756%
- Food & beverage$43044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $537 |
| Stryker | 2 | $200 |
| Elucent Medical | 1 | $144 |
| Baxter Healthcare | 1 | $86 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Truqap$537
- MOLLI$286
- SPY-PHI SYSTEM$143
How this compares
$967 in reported general payments places this provider in the 45th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other surgery in Philadelphia
- Brett ChatmanPhiladelphia$178K
- David WernsingPhiladelphia$142K
- Said AzouryPhiladelphia$131K
- James MarkmannPhiladelphia$97K
- Daniel HewittPhiladelphia$89K
- Daniel HashimotoPhiladelphia$73K
- Scott KozinPhiladelphia$59K
- Prashanth PalvannanPhiladelphia$54K
- Henry HirschPhiladelphia$53K
- Erica PettkePhiladelphia$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.